Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Acquisitions (2022)

iBio (IBIO) has disclosed Acquisitions for 1 consecutive years, with $692000.0 as the latest value for Q3 2022.

  • Quarterly Acquisitions changed N/A to $692000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $692000.0 through Jun 2023, changed N/A year-over-year, with the annual reading at $692000.0 for FY2023, N/A changed from the prior year.
  • Acquisitions for Q3 2022 was $692000.0 at iBio.
  • The five-year high for Acquisitions was $692000.0 in Q3 2022, with the low at $692000.0 in Q3 2022.